# Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes

> **NCT02716610** · PHASE1,PHASE2 · COMPLETED · sponsor: **Dance Biopharm Inc.** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** INH 69 U (low)
- **DRUG:** INH 69 U (high)
- **DRUG:** INH 139 U
- **DRUG:** INH 208 U
- **DRUG:** LIS 18 U

## Key facts

- **NCT ID:** NCT02716610
- **Lead sponsor:** Dance Biopharm Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716610, "Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02716610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*